259 related articles for article (PubMed ID: 28458583)
1. Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.
Tiller H; Husebekk A; Ahlen MT; Stuge TB; Skogen B
Int J Womens Health; 2017; 9():223-234. PubMed ID: 28458583
[TBL] [Abstract][Full Text] [Related]
2. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
Uhrynowska ME; Dębska M; Guz K; Orzińska A; Wróbel A; Maślanka K; Dębski R; Brojer E
Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877
[TBL] [Abstract][Full Text] [Related]
3. Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia.
Vadasz B; Chen P; Yougbaré I; Zdravic D; Li J; Li C; Carrim N; Ni H
Genes Dis; 2015 Jun; 2(2):173-185. PubMed ID: 28345015
[TBL] [Abstract][Full Text] [Related]
4. Fetal and neonatal alloimmune thrombocytopenia.
Zdravic D; Yougbare I; Vadasz B; Li C; Marshall AH; Chen P; Kjeldsen-Kragh J; Ni H
Semin Fetal Neonatal Med; 2016 Feb; 21(1):19-27. PubMed ID: 26810319
[TBL] [Abstract][Full Text] [Related]
5. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
Bonstein L; Haddad N
Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
[TBL] [Abstract][Full Text] [Related]
6. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?
Radder CM; Brand A; Kanhai HH
Vox Sang; 2003 May; 84(4):318-25. PubMed ID: 12757506
[TBL] [Abstract][Full Text] [Related]
7. The use of IVIg in fetal and neonatal alloimmune thrombocytopenia- Principles and mechanisms.
Wabnitz H; Khan R; Lazarus AH
Transfus Apher Sci; 2020 Feb; 59(1):102710. PubMed ID: 31926738
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-Antibody specificity analysis using epitope data.
Dahl J; Refsum E; Ahlen MT; Egeland T; Jensen T; Viken MK; Stuge TB; Acharya G; Husebekk A; Skogen B; Tiller H
J Reprod Immunol; 2017 Aug; 122():1-9. PubMed ID: 28686909
[TBL] [Abstract][Full Text] [Related]
9. Management of neonatal thrombocytopenia in a context of maternal antiplatelet alloimmunization: Expert opinion of the French-speaking working group.
Bertrand G; Blouin L; Boehlen F; Levine E; Minon JM; Winer N;
Arch Pediatr; 2019 Apr; 26(3):191-197. PubMed ID: 30827773
[TBL] [Abstract][Full Text] [Related]
10. Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia.
Li C; Chen P; Vadasz B; Ma L; Zhou H; Lang S; Freedman J; Ni H
Thromb Haemost; 2013 Dec; 110(6):1250-8. PubMed ID: 24067944
[TBL] [Abstract][Full Text] [Related]
11. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
12. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
Cook TJ; Qiu CC; Dickinson JE
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050
[TBL] [Abstract][Full Text] [Related]
13. Fetal/neonatal alloimmune thrombocytopenia.
Sachs UJ
Thromb Res; 2013 Jan; 131 Suppl 1():S42-6. PubMed ID: 23452741
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia.
Curtis BR
Br J Haematol; 2015 Dec; 171(5):671-82. PubMed ID: 26344048
[TBL] [Abstract][Full Text] [Related]
15. Fetal and neonatal alloimmune thrombocytopenia.
van den Akker ES; Oepkes D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
[TBL] [Abstract][Full Text] [Related]
16. Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets.
Refsum E; Meinke S; Gryfelt G; Wikman A; Höglund P
Thromb Res; 2018 Feb; 162():69-76. PubMed ID: 29306729
[TBL] [Abstract][Full Text] [Related]
17. Fetal and Neonatal Alloimmune Thrombocytopenia: Management and Outcome of a Large International Retrospective Cohort.
Kamphuis MM; Tiller H; van den Akker ES; Westgren M; Tiblad E; Oepkes D
Fetal Diagn Ther; 2017; 41(4):251-257. PubMed ID: 27728915
[TBL] [Abstract][Full Text] [Related]
18. Alloimmune thrombocytopenia of the fetus and the newborn.
Kaplan C
Blood Rev; 2002 Mar; 16(1):69-72. PubMed ID: 11914000
[TBL] [Abstract][Full Text] [Related]
19. Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature.
Winkelhorst D; Kamphuis MM; de Kloet LC; Zwaginga JJ; Oepkes D; Lopriore E
Transfusion; 2016 May; 56(5):1230-5. PubMed ID: 26996515
[TBL] [Abstract][Full Text] [Related]
20. Fetal and neonatal alloimmune thrombocytopenia.
Constantinescu S; Zamfirescu V; Vladareanu PR
Maedica (Bucur); 2012 Dec; 7(4):372-6. PubMed ID: 23482913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
